Literature DB >> 8100480

p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan.

H Nose1, F Imazeki, M Ohto, M Omata.   

Abstract

BACKGROUND: p53 gene mutations at codon 249 have been reported in hepatocellular carcinoma (HCC) from China and South Africa, a phenomenon shown to be closely associated with food contamination by aflatoxin. There have been few reports, however, in regard to p53 gene mutations in HCC from other geographic areas.
METHODS: The authors analyzed 20 HCC from Japan for alteration of the p53 gene by restriction fragment length polymorphisms and for nucleic acid mutations by polymerase chain reaction with direct sequencing.
RESULTS: Alterations associated with the p53 gene were found in 6 of 20 HCC (30%). Allelic loss of chromosome 17p occurred in 5 of 14 informative (heterozygous) cases (36%). Mutations in the p53 gene were detected in three cases (15%), at codons 176 (exon 5), 236 (exon 7), and 294 (exon 8). These cases were different from the HCC cases from China and South Africa, where point mutations in the p53 gene were reported at the same codon 249 in half of the cases and where aflatoxin food contamination and hepatitis B virus infection are recognized risk factors of HCC. No p53 gene alterations were found in smaller HCC (< 3 cm) or at earlier stages.
CONCLUSIONS: In Japan, p53 gene alterations seem to be a late event in the progression of hepatocarcinogenesis, which is often associated with persistent infection by the hepatitis C or B virus, but not usually with exposure to aflatoxin.

Entities:  

Mesh:

Year:  1993        PMID: 8100480     DOI: 10.1002/1097-0142(19930715)72:2<355::aid-cncr2820720208>3.0.co;2-w

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis.

Authors:  Nicole M Kettner; Horatio Voicu; Milton J Finegold; Cristian Coarfa; Arun Sreekumar; Nagireddy Putluri; Chinenye A Katchy; Choogon Lee; David D Moore; Loning Fu
Journal:  Cancer Cell       Date:  2016-11-23       Impact factor: 31.743

Review 2.  MDM2-p53 pathway in hepatocellular carcinoma.

Authors:  Xuan Meng; Derek A Franklin; Jiahong Dong; Yanping Zhang
Journal:  Cancer Res       Date:  2014-12-04       Impact factor: 12.701

Review 3.  Hepatocellular carcinoma p53 G > T transversions at codon 249: the fingerprint of aflatoxin exposure?

Authors:  T Lasky; L Magder
Journal:  Environ Health Perspect       Date:  1997-04       Impact factor: 9.031

4.  p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation.

Authors:  K Honda; E Sbisà; A Tullo; P A Papeo; C Saccone; S Poole; M Pignatelli; R R Mitry; S Ding; A Isla; A Davies; N A Habib
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

5.  Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.

Authors:  J C Sheu; Y W Lin; H C Chou; G T Huang; H S Lee; Y H Lin; S Y Huang; C H Chen; J T Wang; P H Lee; J T Lin; F J Lu; D S Chen
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

6.  Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.

Authors:  A Rashid; J S Wang; G S Qian; B X Lu; S R Hamilton; J D Groopman
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

Review 7.  Potential therapeutic targets of TP53 gene in the context of its classically canonical functions and its latest non-canonical functions in human cancer.

Authors:  Toshimichi Tanaka; Masahiko Watanabe; Keishi Yamashita
Journal:  Oncotarget       Date:  2018-03-23

8.  RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.

Authors:  Jiazhou Ye; Rong Liang; Tao Bai; Yan Lin; Rongyun Mai; Meng Wei; Xinqin Ye; Lequn Li; Feixiang Wu
Journal:  J Exp Clin Cancer Res       Date:  2018-09-03

9.  Development of a transgenic mouse model of hepatocellular carcinoma with a liver fibrosis background.

Authors:  Sook In Chung; Hyuk Moon; Dae Yeong Kim; Kyung Joo Cho; Hye-Lim Ju; Do Young Kim; Sang Hoon Ahn; Kwang-Hyub Han; Simon Weonsang Ro
Journal:  BMC Gastroenterol       Date:  2016-01-29       Impact factor: 3.067

10.  p53 gene mutations in human prostate cancers in Japan: different mutation spectra between Japan and western countries.

Authors:  M Watanabe; T Ushijima; H Kakiuchi; T Shiraishi; R Yatani; J Shimazaki; T Kotake; T Sugimura; M Nagao
Journal:  Jpn J Cancer Res       Date:  1994-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.